A detailed history of Intech Investment Management LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 35,989 shares of AVIR stock, worth $113,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,989
Previous 10,711 236.0%
Holding current value
$113,365
Previous $35,000 242.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$2.93 - $3.82 $74,064 - $96,561
25,278 Added 236.0%
35,989 $120,000
Q3 2024

Nov 08, 2024

BUY
$3.17 - $4.02 $33,953 - $43,058
10,711 New
10,711 $35,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $262M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.